AAAAAA

   
Results: 1-21 |
Results: 21
PRAVASTATIN PREVENTS ISCHEMIC EVENTS AFTER ANGIOPLASTY IN MYOCARDIAL-INFARCTION PATIENTS WITH AN AVERAGE CHOLESTEROL
Authors: WARNICA JW FLAKER GC MOYE L SACKS F
Citation: Jw. Warnica et al., PRAVASTATIN PREVENTS ISCHEMIC EVENTS AFTER ANGIOPLASTY IN MYOCARDIAL-INFARCTION PATIENTS WITH AN AVERAGE CHOLESTEROL, Journal of the American College of Cardiology, 31(2), 1998, pp. 404-404
PREVENTION OF A FIRST STROKE BY TRANSFUSIONS IN CHILDREN WITH SICKLE,CELL ANEMIA AND ABNORMAL RESULTS ON TRANSCRANIAL DOPPLER ULTRASONOGRAPHY
Authors: ADAMS RJ MCKIE VC HSU L FILES B VICHINSKY E PEGELOW C ABBOUD M GALLAGHER D KUTLAR A NICHOLS FT BONDS DR BRAMBILLA D WOODS G OLIVIERI N DRISCOLL C MILLER S WANG W HURLETT A SCHER C BERMAN B CARL E JONES AM ROACH ES WRIGHT E ZIMMERMAN RA WACLAWIW M PEARSON H POWARS D YOUNKIN D ELGAMMAL T SEIBERT J MOYE L ESPELAND M MURRAY R MCKINLEY R MCKINLEY S HAGNER S WEINER S ESTOW S YELLE M BROCK K CARTER E CHIARUCCI K DEBARR M FERON P HARRIS S HOEY L JACQUES K KUISEL L LEWIS N LINDSEY R MARTIN B MCMEECHAN C MURACCA M REY K ROATH G HACKNEYSTEPHENS E SUMTER L TALBOT A TAPLIN G WHITTLE C WOODS P HARBIN J HOLLEY L JACKSON B KUTLAR F MILLER B ODO N SAHM M SCHWEITZER J WINSTEAD A SWIFT T ALLEN F ALLEN K BEASLEY M EJANTKAR A HOUSTON E HUNTER D LUDEN J OTTENLIPS J TROCIO S HERNANDEZ C MCKIE K MCMORROWTOUHY AM PERRY R BELLO J LUBAN N MOSER F CAPLAN L DEWITT D RIELA A BABYN P CURE J DAVIS P FIQUEROA R GAENSLER E HOTSON W KODROFF M LANGSTON J LEWIN J RHO T SEIDEL G SUTTON C VEZINA G WHITMAN M ALMATEEN M BARFIELD J CARAGAN A CURLESS R FACCHINI S FLEMMING F HOLDEN K MACGREGOR D MURPHY J PACKER R PARK Y ROSE A SUTTON C WIZNITZER M
Citation: Rj. Adams et al., PREVENTION OF A FIRST STROKE BY TRANSFUSIONS IN CHILDREN WITH SICKLE,CELL ANEMIA AND ABNORMAL RESULTS ON TRANSCRANIAL DOPPLER ULTRASONOGRAPHY, The New England journal of medicine, 339(1), 1998, pp. 5-11
INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS
Authors: FRANZOSI MG SANTORO E ZUANETTI G BAIGENT C COLLINS R FLATHER M KJEKSHUS J LATINI R LIU LS MAGGIONI AP SLEIGHT P SWEDBERG K TOGNONI G YUSUF S TAVAZZI L BALL S KOBER L TORPPEDERSEN C BRAUNWALD E MOYE L PFEFFER M SANTORO L POGUE J WANG Y
Citation: Mg. Franzosi et al., INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS, Circulation, 97(22), 1998, pp. 2202-2212
BENEFIT OF CHOLESTEROL REDUCTION WITH PRAVASTATIN IN POST-MI PATIENTSIRRESPECTIVE OF FASTING GLUCOSE-LEVELS
Authors: GOLDBERG R MOYE L HOWARD B HOWARD WJ MELLIES M SACKS F BRAUNWALD E
Citation: R. Goldberg et al., BENEFIT OF CHOLESTEROL REDUCTION WITH PRAVASTATIN IN POST-MI PATIENTSIRRESPECTIVE OF FASTING GLUCOSE-LEVELS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7182-7182
OLDER PATIENTS IN CARE BENEFIT FROM PRAVASTATIN POST MYOCARDIAL-INFARCTION
Authors: LEWIS SJ MITCHELL J EAST C GLASSER SP GRANT J JOHNSTONE DE KELL S LETTERER R LIMACHER M TIMMIS GC MOYE L ROULEAU J PFEFFER MA SACKS FM BRAUNWALD E
Citation: Sj. Lewis et al., OLDER PATIENTS IN CARE BENEFIT FROM PRAVASTATIN POST MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 7871-7871
ADDITIVE BENEFICIAL-EFFECTS OF BETA-BLOCKERS TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE SURVIVAL AND VENTRICULAR ENLARGEMENT (SAVE)STUDY
Authors: VANTRIMPONT P ROULEAU JL WUN CC CIAMPI A KLEIN M SUSSEX B ARNOLD JMO MOYE L PFEFFER M
Citation: P. Vantrimpont et al., ADDITIVE BENEFICIAL-EFFECTS OF BETA-BLOCKERS TO ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE SURVIVAL AND VENTRICULAR ENLARGEMENT (SAVE)STUDY, Journal of the American College of Cardiology, 29(2), 1997, pp. 229-236
CHOLESTEROL REDUCTION WITH PRAVASTATIN IN CARE PATIENTS IS BENEFICIALIRRESPECTIVE OF FASTING GLUCOSE-LEVELS
Authors: GOLDBERG R MOYE L HOWARD B HOWARD WH MELLIES M SACKS FM BRAUNWALD E
Citation: R. Goldberg et al., CHOLESTEROL REDUCTION WITH PRAVASTATIN IN CARE PATIENTS IS BENEFICIALIRRESPECTIVE OF FASTING GLUCOSE-LEVELS, Atherosclerosis, 134(1-2), 1997, pp. 47-47
CLINICAL-SIGNIFICANCE OF MITRAL REGURGITATION AFTER ACUTE MYOCARDIAL-INFARCTION
Authors: LAMAS GA MITCHELL GF FLAKER GC SMITH SC GERSH BJ BASTA L MOYE L BRAUNWALD E PFEFFER MA
Citation: Ga. Lamas et al., CLINICAL-SIGNIFICANCE OF MITRAL REGURGITATION AFTER ACUTE MYOCARDIAL-INFARCTION, Circulation, 96(3), 1997, pp. 827-833
CARDIOVASCULAR DEATH AND LEFT-VENTRICULAR REMODELING 2 YEARS AFTER MYOCARDIAL-INFARCTION - BASE-LINE PREDICTORS AND IMPACT OF LONG-TERM USEOF CAPTOPRIL - INFORMATION FROM THE SURVIVAL AND VENTRICULAR ENLARGEMENT (SAVE) TRIAL
Authors: SUTTON MS PFEFFER MA MOYE L PLAPPERT T ROULEAU JL LAMAS G ROULEAU J PARKER JO ARNOLD MO SUSSEX B BRAUNWALD E
Citation: Ms. Sutton et al., CARDIOVASCULAR DEATH AND LEFT-VENTRICULAR REMODELING 2 YEARS AFTER MYOCARDIAL-INFARCTION - BASE-LINE PREDICTORS AND IMPACT OF LONG-TERM USEOF CAPTOPRIL - INFORMATION FROM THE SURVIVAL AND VENTRICULAR ENLARGEMENT (SAVE) TRIAL, Circulation, 96(10), 1997, pp. 3294-3299
DIABETIC RESPONSE TO PRAVASTATIN DURING THE CARE STUDY
Authors: GOLDBERG R SACKS F HOWARD B MOYE L COLE T MELLIES MJ HOWARD J
Citation: R. Goldberg et al., DIABETIC RESPONSE TO PRAVASTATIN DURING THE CARE STUDY, Circulation, 94(8), 1996, pp. 3159-3159
DOSE-RESPONSE RELATION BETWEEN TERFENADINE (SELDANE) AND THE QTC INTERVAL ON THE SCALAR ELECTROCARDIOGRAM - DISTINGUISHING A DRUG EFFECT FROM SPONTANEOUS VARIABILITY
Authors: PRATT CM RUBERG S MORGANROTH J MCNUTT B WOODWARD J HARRIS S RUSKIN J MOYE L
Citation: Cm. Pratt et al., DOSE-RESPONSE RELATION BETWEEN TERFENADINE (SELDANE) AND THE QTC INTERVAL ON THE SCALAR ELECTROCARDIOGRAM - DISTINGUISHING A DRUG EFFECT FROM SPONTANEOUS VARIABILITY, The American heart journal, 131(3), 1996, pp. 472-480
EFFECT OF INFARCT ARTERY PATENCY ON PROGNOSIS AFTER ACUTE MYOCARDIAL-INFARCTION
Authors: LAMAS GA FLAKER GC MITCHELL G SMITH SC GERSH BJ WUN CC MOYE L ROULEAU JL RUTHERFORD JD PFEFFER MA BRAUNWALD E
Citation: Ga. Lamas et al., EFFECT OF INFARCT ARTERY PATENCY ON PROGNOSIS AFTER ACUTE MYOCARDIAL-INFARCTION, Circulation, 92(5), 1995, pp. 1101-1109
PHYSICAL WORKING CAPACITY AFTER ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITH LOW EJECTION FRACTION AND EFFECT OF CAPTOPRIL
Authors: HARTLEY LH FLAKER G BASTA L MENAPACE F GOLDMAN S DAVIS B HAMM P LAMAS G MOYE L WUN CC PFEFFER M
Citation: Lh. Hartley et al., PHYSICAL WORKING CAPACITY AFTER ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITH LOW EJECTION FRACTION AND EFFECT OF CAPTOPRIL, The American journal of cardiology, 76(12), 1995, pp. 857-860
DESIGN, RATIONALE, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT - A COMBINED ANALYSIS OF 3 LARGE-SCALE RANDOMIZED TRIALS - LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC-DISEASE (LIPID), CHOLESTEROL AND RECURRENT EVENTS (CARE), AND WESTOF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS)
Authors: FURBERG C BYINGTON RP BAKER JL COBBE SM DAVIS B FORD I GLASZIOU P HAWKINS CM KEECH AC MACMAHON S MOYE L PACKARD C PFEFFER MA SACKS FM SHEPHERD J SIMES J TONKIN A MELLIES M MCGOVERN M NICHOLAS S ANDERSON S PARK JS BARNHART M FORTUNATO J
Citation: C. Furberg et al., DESIGN, RATIONALE, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT - A COMBINED ANALYSIS OF 3 LARGE-SCALE RANDOMIZED TRIALS - LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC-DISEASE (LIPID), CHOLESTEROL AND RECURRENT EVENTS (CARE), AND WESTOF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS), The American journal of cardiology, 76(12), 1995, pp. 899-905
THE RISK OF LIFE-THREATENING CARDIOVASCULAR EVENTS WITH TERFENADINE -REPLY
Authors: PRATT CM MOYE L HERTZ RP
Citation: Cm. Pratt et al., THE RISK OF LIFE-THREATENING CARDIOVASCULAR EVENTS WITH TERFENADINE -REPLY, The American journal of cardiology, 75(2), 1995, pp. 214-214
PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS
Authors: DOWNS JR GOTTO A CLEARFIELD M GORDON D MANOLIO T GOLDBOURT U KAPLINSKY E MOYE L SACKS F PFEFFER M HAWKINS CM BRAUNWALD E FRANZOSI MG MAGGIONI A TOGNONI G ROBINS S RUBINS H SIMES J KEECH A MACMAHON S TONKIN A YUSUF S FLATHER M COLLINS R KEECH A ARMITAGE J BAIGENT C PETO R SLEIGHT P KNATTERUD G KJEKSHUS J PEDERSEN T WILHELMSEN L ROUSSOUW J PROBSTFIELD J COBBE S MACFARLANE P SHEPHERD J
Citation: Jr. Downs et al., PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS, The American journal of cardiology, 75(16), 1995, pp. 1130-1134
PROGNOSTIC VALUE OF NEUROHUMORAL ACTIVATION IN PATIENTS WITH AN ACUTEMYOCARDIAL-INFARCTION - EFFECT OF CAPTOPRIL
Authors: ROULEAU JL PACKER M MOYE L DECHAMPLAIN J BICHET D KLEIN M ROULEAU JR SUSSEX B ARNOLD JM SESTIER F PARKER JO MCEWAN P BERNSTEIN V CUDDY TE LAMAS G GOTTLIEB SS MCCANS J NADEAU C DELAGE F WUN CCC PFEFFER MA
Citation: Jl. Rouleau et al., PROGNOSTIC VALUE OF NEUROHUMORAL ACTIVATION IN PATIENTS WITH AN ACUTEMYOCARDIAL-INFARCTION - EFFECT OF CAPTOPRIL, Journal of the American College of Cardiology, 24(3), 1994, pp. 583-591
N-TERMINAL PROATRIAL NATRIURETIC FACTOR - AN INDEPENDENT PREDICTOR OFLONG-TERM PROGNOSIS AFTER MYOCARDIAL-INFARCTION
Authors: HALL C ROULEAU JL MOYE L DECHAMPLAIN J BICHET D KLEIN M SUSSEX B PACKER M ROULEAU J ARNOLD MO LAMAS GA SESTIER F GOTTLIEB SS WUN CCC PFEFFER MA
Citation: C. Hall et al., N-TERMINAL PROATRIAL NATRIURETIC FACTOR - AN INDEPENDENT PREDICTOR OFLONG-TERM PROGNOSIS AFTER MYOCARDIAL-INFARCTION, Circulation, 89(5), 1994, pp. 1934-1942
IMPACT OF THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION ON BEHAVIORAL VARIABLES - RESULTS FROM THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM
Authors: APPLEGATE WB PRESSEL S WITTES J LUHR J SHEKELLE RB CAMEL GH GREENLICK MR HADLEY E MOYE L PERRY HM SCHRON E WEGENER V
Citation: Wb. Applegate et al., IMPACT OF THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION ON BEHAVIORAL VARIABLES - RESULTS FROM THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM, Archives of internal medicine, 154(19), 1994, pp. 2154-2160
RISK OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIA ASSOCIATEDWITH TERFENADINE IN COMPARISON WITH OVER-THE-COUNTER ANTIHISTAMINES, IBUPROFEN AND CLEMASTINE
Authors: PRATT CM HERTZ RP ELLIS BE CROWELL SP LOUV W MOYE L
Citation: Cm. Pratt et al., RISK OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIA ASSOCIATEDWITH TERFENADINE IN COMPARISON WITH OVER-THE-COUNTER ANTIHISTAMINES, IBUPROFEN AND CLEMASTINE, The American journal of cardiology, 73(5), 1994, pp. 346-352
PROGNOSTIC VALUE OF POSTINFARCTION NEUROHUMORAL ACTIVATION - EFFECT OF CAPTOPRIL
Authors: ROULEAU JL PACKER M MOYE L DECHAMPLAIN J BICHET D KLEIN M ROULEAU JR SUSSEX B ARNOLD M SESTIER F PARKER JO MCEWAN P BERNSTEIN V CUDDY TE NADEAU C WUN CCC PFEFFER M
Citation: Jl. Rouleau et al., PROGNOSTIC VALUE OF POSTINFARCTION NEUROHUMORAL ACTIVATION - EFFECT OF CAPTOPRIL, Circulation, 88(4), 1993, pp. 394-394
Risultati: 1-21 |